SEC Form 4 · accession 0001144204-18-062709
Cellectar Biosciences, Inc. · CLRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hill
Director
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 6:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2018 | S | 939 | $2.2101 | D | 53 | D | |
| Common Stock | Nov 29, 2018 | S | 53 | $2.21 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Warrants | $30.40 | Nov 29, 2018 | S | 9,390 | A | Apr 20, 2016 | Apr 20, 2021 | Common Stock | 9,390 | 0 | D |
| Warrants | $468.00 | Nov 29, 2018 | S | 530 | A | Aug 20, 2014 | Aug 20, 2019 | Common Stock | 530 | 0 | D |